TABLE 3.
Reference | Treatment | Principle Differences Between Clusters | Notable Clustering Variables | Sensitivity Analysis | External Validation |
---|---|---|---|---|---|
Geri et al (12) | IV fluids | Hemodynamic state | Transesophageal echocardiography measurements | No | No |
Seymour et al (13) | Eritoran, early goal-directed therapy, and recombinant activated protein C | Inflammation and coagulation | Creatinine, blood urea nitrogen, liver function tests, erythrocyte sedimentation rate, albumin, lactate, bicarbonate, troponin | Yes | Yes |
Han et al (18) | Antibiotics | Response to antibiotic delays | Lactate, age, and sex | Yes | No |
Kudo et al (19) | Thrombomodulin | Response to thrombomodulin | Fibrin degradation products, d-dimer | Yes | Yes |
Antcliffe et al (22) | Hydrocortisone | Immunocompetence vs suppression | Gene expression | Yes | Other: Clustering method previously discovered so no validation was performed |
Liu et al (25) | Early antibiotics, fluids, or vasopressors | Risk of progression to septic shock | Lactate, systolic blood pressure, cardiac SOFA, creatinine, Glasgow Coma Scale, Pao2, urine output, Resp SOFA | Yes | No |
Zhang et al (29) | Hydrocortisone | Immunosuppression | Gene expression | Yes | Yes |
SOFA = Sequential Organ Failure Assessment.